Effects of primary chemotherapy on biological parameters of locally advanced breast cancer

Ann N Y Acad Sci. 1996 Apr 30:784:419-26. doi: 10.1111/j.1749-6632.1996.tb16256.x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Epirubicin / administration & dosage
  • Evaluation Studies as Topic
  • Female
  • Fluorouracil / administration & dosage
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Methotrexate / administration & dosage
  • Middle Aged
  • Prospective Studies
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-bcl-2
  • Receptor, IGF Type 1 / metabolism*
  • Thymidine / metabolism*
  • Treatment Outcome
  • Tritium

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Tritium
  • Epirubicin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cyclophosphamide
  • Receptor, IGF Type 1
  • Cisplatin
  • Fluorouracil
  • Thymidine
  • Methotrexate

Supplementary concepts

  • CMF protocol
  • FEC protocol